Join our Newsletter — 33% off our NHI Course
Home› FAQ› Governance, Ownership & Risk› How should healthcare organizations reduce the security risk…
Governance, Ownership & Risk

How should healthcare organizations reduce the security risk of shadow IT without slowing down legitimate clinical work?

← Back to all FAQ
By NHI Mgmt Group Editorial Team Updated September 27, 2026 Domain: Governance, Ownership & Risk

Healthcare teams should combine policy, education, and discovery rather than relying on any single control. Staff need clear rules for sanctioned software, devices, and cloud services, while security teams should run automated and manual discovery to find unsanctioned assets. Continuous monitoring then helps verify what is being used, where sensitive data may flow, and which services need governance or removal.

Why Shadow IT Becomes a Clinical Safety Problem, Not Just a Policy Problem

Shadow IT is risky in healthcare because unsanctioned tools can move patient data, bypass retention rules, and create access paths the security team cannot see or govern. The danger is not only that a tool is unapproved, but that it may sit outside backup, logging, incident response, and vendor oversight processes while still being used in real care workflows.

Healthcare organizations need to treat shadow IT as a visibility and control problem across endpoints, cloud services, and clinical workflows. That means the objective is not to block every unsanctioned workflow immediately, but to distinguish low-risk convenience use from tools that handle sensitive data, integrate with core systems, or create unmanaged authentication and sharing paths.

Where the issue involves access to systems or data, security teams should align discovery with NIST Cybersecurity Framework 2.0 so that unsanctioned tools are not treated as a one-time inventory exercise. The practical question is which assets, users, and data flows should be governed, reduced, or removed because they create measurable exposure.

How to Reduce Risk Without Slowing Legitimate Care

The fastest way to make shadow IT worse is to respond only with prohibition. Clinicians will route around controls when approved tools are too slow, too hard to use, or do not fit the pace of care. A better model is to pair clear approval criteria with a simple intake path so staff know what is allowed, what needs review, and what can be used temporarily under defined guardrails.

Discovery should combine endpoint visibility, network or cloud monitoring, and manual outreach to departments where informal tool adoption is common. That broader view helps find both obvious consumer apps and quieter workflow tools, such as file-sharing plugins, messaging apps, scheduling tools, or browser-based services that can still expose protected information.

For organizations trying to formalize monitoring and control selection, NIST SP 800-53 Rev 5 Security and Privacy Controls is a useful anchor because the problem spans inventory, access control, auditability, and configuration governance. In practice, that means you need a repeatable way to decide whether a tool can be sanctioned, wrapped in compensating controls, or retired.

Approved alternatives matter as much as detection. If security only removes tools, teams will recreate the same behavior elsewhere. The better pattern is to offer sanctioned options that are easy to access, support mobile and shift-based work, and integrate with existing identity and data-handling rules so clinical teams do not face an operational penalty for choosing the safe path.

What Good Governance Looks Like in Practice

Good shadow IT governance is a triage process, not a one-time ban list. Organizations should classify unsanctioned tools by the kind of data they touch, the systems they connect to, the user population adopting them, and whether they introduce third-party risk, duplicate functionality, or simple convenience use with limited exposure.

When cloud collaboration or file transfer is involved, the problem often overlaps with secret sharing, untracked permissions, and uncontrolled external sharing. That is why a resource like OWASP Non-Human Identity Top 10 can help teams think about the broader control surface around tokens, access paths, and service integrations, even when the initial issue is shadow software rather than a dedicated identity project.

Clinically, the best operating model is one where security and digital health teams jointly decide what must be blocked, what can be monitored, and what deserves rapid approval because it supports patient care. That shared ownership reduces the chance that staff will hide tools from review or keep using them after the organization has lost sight of the data and permissions involved.

Risk and Threat Considerations

Shadow IT becomes dangerous when an unsanctioned tool creates an unmanaged path to patient data, external sharing, or third-party processing. The main risk is loss of visibility: once security cannot see the asset, it cannot reliably verify access, retention, logging, or incident response coverage.

Failure mechanism: Staff adopt a tool because it is faster than the approved alternative, but the tool then stores, forwards, or synchronizes data outside monitored controls. That can create hidden duplication, uncontrolled sharing, and an ungoverned dependency on a service that was never reviewed for healthcare use.

Impact: The organization can lose control over sensitive information, complicate breach response, and create compliance gaps even when the original use was well intentioned. At scale, many small exceptions can turn into a large exposure surface that is hard to inventory or unwind.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

NIST CSF 2.0, NIST SP 800-53 Rev 5 and CIS Controls v8 set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.

FrameworkControl / ReferenceRelevance
NIST CSF 2.0GV.OC-01 — Organizational ContextShadow IT governance depends on knowing which workflows and data uses matter most in healthcare.
ID.AM-01 — Physical Devices and Systems InventoriedDiscovery of unsanctioned software and endpoints is an inventory problem first.
PR.AA-01 — Identities and Credentials Issued, Managed, Verified, Revoked, and AuditedShadow IT often creates unmanaged access paths and credentials that bypass governance.
Recommendation — Define which clinical workflows and data flows require sanctioning and tighter governance. Inventory devices and systems that may host or expose shadow IT. Verify and revoke unapproved access paths tied to unsanctioned tools.
NIST SP 800-53 Rev 5CM-8 — System Component InventoryShadow IT reduction starts with discovering and tracking assets and services.
AC-6 — Least PrivilegeShadow tools often expand access beyond what clinical work actually requires.
AU-2 — Event LoggingMonitoring and auditability are central when unsanctioned tools may handle sensitive data.
Recommendation — Maintain an inventory of approved and discovered tools, services, and components. Limit access and permissions to the minimum needed for each approved tool. Log relevant activity so shadow IT use can be investigated and governed.
ISO/IEC 27001:2022A.5.9 — Inventory of information and other associated assetsAsset visibility is essential to finding unsanctioned tools and dependencies.
Recommendation — Keep an accurate inventory of approved and discovered information assets.
CIS Controls v8CIS-1 — Inventory and Control of Enterprise AssetsShadow IT is fundamentally an unmanaged asset problem across endpoints and services.
Recommendation — Continuously inventory devices, software, and services to find unapproved use.

Practitioner Guidance

What to prioritise: Focus first on tools that touch protected data, connect to core systems, or enable external sharing. Those are the cases where discovery and containment have the highest risk reduction value.

What to verify: Before sanctioning or tolerating a tool, verify who can access the data, where it is stored, whether logs exist, and whether the vendor relationship is actually supportable under your governance model.

Decision rule: If the tool is only a convenience workaround with no sensitive data and no system integration, monitor and educate; if it processes patient information or credentials, move it into formal review immediately.

Practitioner takeaway: The right balance is not “strictly allowed or strictly banned,” but “visible, risk-ranked, and governable,” so clinicians keep working while unmanaged data paths steadily shrink.

Deepen Your Knowledge

Sign up to our weekly newsletter — get 33% off our NHI Foundation Level Course

    NHIMG Editorial Note
    Reviewed and updated by the NHIMG editorial team on September 27, 2026.
    NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org